[REGN] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
05-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -21.14%
YoY- 35.46%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 2,422,900 2,294,000 1,952,000 1,828,200 2,169,500 2,048,400 1,933,700 16.14%
PBT 1,224,600 998,300 918,900 668,600 889,800 768,500 224,700 208.10%
Tax 75,400 156,200 21,600 44,000 97,800 98,900 31,600 78.09%
NP 1,149,200 842,100 897,300 624,600 792,000 669,600 193,100 226.63%
Tax Rate -6.16% -15.65% -2.35% -6.58% -10.99% -12.87% -14.06% -
Total Cost 1,273,700 1,451,900 1,054,700 1,203,600 1,377,500 1,378,800 1,740,600 -18.71%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 47.43 36.71 45.97 34.16 36.51 32.69 9.99 181.15%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS 10.90 7.98 8.19 5.69 7.25 6.12 1.77 234.12%
EPS Diluted 10.24 7.39 7.61 5.43 6.93 5.86 1.68 231.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.